Lercaril 20 mg/20 mg Film-coated Tablets
*Company:
Recordati Ireland LimitedStatus:
UpdatedLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 19 April 2024
File name
IE_Lercaril 20-20_SmPC_July2021.pdf
Reasons for updating
- Change to section 6.1 - List of excipients
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
This medicine contains less than 1 mmol sodium (23 mg) per tablet that is to say essentially “sodiumfree”.
Updated on 19 April 2024
File name
IE_Lercaril 20-20_PIL_April2021.pdf
Reasons for updating
- Change to section 2 - excipient warnings
Free text change information supplied by the pharmaceutical company
This medicine contains less than 1 mmol sodium (23 mg) per tablet that is to say essentially “sodiumfree”.
Updated on 22 December 2019
File name
lercaril-20mg-20mg-spc-July 2019.pdf
Reasons for updating
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.8 - Undesirable effects
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 4.9 - Overdose
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 22 December 2019
File name
lercaril-20mg-20mg-pil-July 2019.pdf
Reasons for updating
- New PIL for new product
Updated on 22 December 2019
File name
lercaril-20mg-10mg-spc-July 2019.pdf
Reasons for updating
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.8 - Undesirable effects
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 4.9 - Overdose
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 15 January 2019
File name
IE_Lercaril 20-20mg_SmPC_122018.pdf
Reasons for updating
- Change to section 9 - Date of first authorisation/renewal of the authorisation
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 15 January 2019
File name
IE_Lercaril 20-20mg_SmPC_122018.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)